| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.21B | 18.07B | 17.36B | 17.33B | 16.68B | 15.43B |
| Gross Profit | 3.52B | 3.64B | 3.54B | 3.47B | 3.31B | 2.98B |
| EBITDA | 1.66B | 1.84B | 1.76B | 1.88B | 1.77B | 1.41B |
| Net Income | 1.17B | 1.29B | 1.18B | 1.29B | 1.21B | 937.00M |
Balance Sheet | ||||||
| Total Assets | 12.95B | 14.43B | 13.59B | 12.88B | 12.26B | 11.22B |
| Cash, Cash Equivalents and Short-Term Investments | 8.26B | 9.47B | 9.85B | 8.47B | 7.39B | 6.36B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 2.37B | 2.65B | 2.65B | 2.56B | 2.75B | 2.60B |
| Stockholders Equity | 10.59B | 11.78B | 10.94B | 10.31B | 9.51B | 8.62B |
Cash Flow | ||||||
| Free Cash Flow | 1.11B | 739.00M | 1.39B | 1.58B | 902.00M | 1.04B |
| Operating Cash Flow | 1.19B | 766.00M | 1.39B | 1.58B | 948.00M | 1.08B |
| Investing Cash Flow | -71.00M | -32.00M | 23.00M | 15.00M | -76.00M | -38.00M |
| Financing Cash Flow | -1.98B | -510.00M | -640.00M | -507.00M | -347.00M | -437.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥11.61B | 12.86 | ― | 3.56% | 3.96% | -3.68% | |
69 Neutral | ¥16.23B | 191.28 | ― | ― | 14.10% | -53.62% | |
68 Neutral | ¥6.71B | 16.64 | ― | ― | 11.32% | ― | |
66 Neutral | ¥4.90B | 13.29 | ― | ― | 7.60% | 19.13% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥12.34B | 56.91 | ― | ― | 14.63% | -760.87% | |
55 Neutral | ¥5.10B | 26.11 | ― | ― | 4.36% | -0.02% |
HIMACS reported consolidated net sales of ¥13.47 billion for the nine months ended 31 December 2025, a modest 1.1% year-on-year increase, while operating profit, ordinary profit and profit attributable to owners of parent all declined by about 14%, pulling basic earnings per share down to ¥67.65 from ¥78.08. Despite the profit squeeze and a slight contraction in total assets and net assets, the company’s equity ratio remained robust at 81.7%, and management kept its full-year forecast unchanged, targeting ¥20 billion in net sales (+10.7% year-on-year) and broadly flat operating profit, alongside a slight decline in full-year earnings, while reaffirming an increased annual dividend forecast of ¥46 per share, signaling a continued commitment to shareholder returns even amid margin pressure.
The most recent analyst rating on (JP:4299) stock is a Buy with a Yen1567.00 price target. To see the full list of analyst forecasts on HIMACS, Ltd. stock, see the JP:4299 Stock Forecast page.